Zobrazeno 1 - 10
of 168
pro vyhledávání: '"J M, Brogard"'
Autor:
J.-M. Brogard, J.-F. Blicklé
Publikováno v:
Médecine des Maladies Métaboliques. 7:185-190
Resume La decouverte de l’insuline par Frederick G. Banting et Charles H. Best a connu une rapide diffusion sur le continent nord-americain des les annees 1922–1923, mais, en depit de l’industrialisation de l’extraction par les Laboratoires E
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e03700bc089492c3027c3d8ec1055ed7
https://doi.org/10.1016/s1957-2557(13)70523-6
https://doi.org/10.1016/s1957-2557(13)70523-6
Autor:
P. Diemunsch, H. Lambert, D. Grimaud, P. Massabie, P. J. Guillausseau, P Scherpereel, J. M. Brogard
Publikováno v:
Annales Françaises d'Anesthésie et de Réanimation. 14:523-531
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1f58340b37d514881c51fd2cfc816291
https://doi.org/10.1016/s0750-7658(05)80497-6
https://doi.org/10.1016/s0750-7658(05)80497-6
Publikováno v:
Proceedings of the Royal Society of Medicine. 70(Suppl 9)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5be15291602ce97e7729118b8eaecd9d
https://pubmed.ncbi.nlm.nih.gov/20919417
https://pubmed.ncbi.nlm.nih.gov/20919417
Publikováno v:
Journal of Antimicrobial Chemotherapy. 27:647-654
Interest in the intestinal absorption mechanisms of drugs has increased because transepithelial passage across the gut does not necessarily follow a passive diffusion process. Amoxycillin, like other amino-beta-lactam antibiotics, has been demonstrat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::523503377d9e43f2197c538634a5d7c2
https://doi.org/10.1093/jac/27.5.647
https://doi.org/10.1093/jac/27.5.647
Publikováno v:
Pathologie-biologie. 47(8)
The objective of this study was to determine the extent of biliary excretion of tazocillin, a combination of piperacillin and tazobactam administered as an intravenous infusion in a dose of 4 g of piperacillin and 0.5 g of tazobactam. In 10 patients,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2bee7f950bbd66641b26d2b478d6ff41
https://pubmed.ncbi.nlm.nih.gov/10573704
https://pubmed.ncbi.nlm.nih.gov/10573704
Publikováno v:
La Revue de medecine interne. 20
The development of antidiabetic drugs with complementary mechanisms of action appears more and more necessary in order to achieve durable glycaemic control in type 2 diabetes. By inhibiting in a reversible way the hydrolysis of disaccharides and the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::98ac09cff9b5f39ea66d73f6bb8fc7ad
https://pubmed.ncbi.nlm.nih.gov/10480189
https://pubmed.ncbi.nlm.nih.gov/10480189
Publikováno v:
La Revue de medecine interne. 20
The relief of insulin resistance is one of the two therapeutic targets of the treatment of type 2 diabetes. Insulin-sensitizers are therefore complemental with other oral diabetic drugs. The treatment of insulin resistance was for a long time limited
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::594df8ed8447f44ac1ee1dfeda8c72dd
https://pubmed.ncbi.nlm.nih.gov/10480188
https://pubmed.ncbi.nlm.nih.gov/10480188
Publikováno v:
La Revue de medecine interne. 20
The functional defect of the pancreatic beta cell represents one of the main therapeutic targets in type 2 diabetes mellitus. Among the currently available oral antidiabetic drugs, only hypoglycaemic sulfonylureas exhibit beta cell stimulating proper
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::083323cceba2e381977e2441ceaf6892
https://pubmed.ncbi.nlm.nih.gov/10480186
https://pubmed.ncbi.nlm.nih.gov/10480186
Autor:
J F, Blicklé, J M, Brogard
Publikováno v:
La Revue de medecine interne. 20(7)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::23fd6ebd73e3d4ac58f59e46b5395c5e
https://pubmed.ncbi.nlm.nih.gov/10434345
https://pubmed.ncbi.nlm.nih.gov/10434345